It is already well known that insulin sits at the critical center of metabolic disorders, including obesity, diabetes, hyperlipidemia, non-alcoholic fatty liver disease and all risk factors of cardiovascular disease (Kato et al. 2015; Oseini and Sanyal 2017). This evidence concerns the gene INS and metabolic disease.